{
    "Trade/Device Name(s)": [
        "SYNCHRON\u00ae Systems High Sensitivity Cardiac C-Reactive Protein (CRPH) Reagent"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K070626",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033908",
        "K010597"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQD",
        "DCK"
    ],
    "Summary Letter Date": "May 4, 2007",
    "Summary Letter Received Date": "March 6, 2007",
    "Submission Date": "March 2, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.5270"
    ],
    "Regulation Name(s)": [
        "C-reactive protein immunological test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "C-Reactive Protein"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "SYNCHRON LX\u00ae PRO System",
        "UniCel\u00ae DxC 600/800 System(s)",
        "SYNCHRON\u00ae Systems CAL 5 Plus"
    ],
    "Method(s)/Technology(ies)": [
        "Rate turbidimetry",
        "Near Infrared Particle Immunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Turbidimetric assay"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for SYNCHRON Systems High Sensitivity Cardiac C-Reactive Protein (CRPH) Reagent for quantitative determination of CRP in serum or plasma using immunoturbidimetry.",
    "Indications for Use Summary": "For the quantitative determination of C-Reactive Protein in human serum or plasma by rate turbidimetry as an aid in the assessment of risk for cardiovascular disease and evaluation of inflammation.",
    "fda_folder": "Immunology"
}